Skip to main content
OpenTrials
Completed

NCT Number: NCT01460303

Patient-operated Valved Catheter Versus Indwelling Transurethral Catheter

Following surgery for female urinary incontinence and/or pelvic organ prolapse, women are sometimes temporarily unable to empty their bladders and are sent home with a transurethral indwelling catheter attached to a bag which holds urine. The goal of this study is to compare a new type of patient-operated catheter without a bag to the catheter with a bag for ease of use, comfort and quality of life for patients during the postoperative recovery period. This new catheter, the OPTION-vf, is approved by the FDA and is available on the market.

Completed

Looking for future studies?

Notify Me

Key information

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • patients undergoing surgery for urinary incontinence and/or pelvic organ prolapse at the UMass Memorial Medical Center with one of the Urogynecology/Reconstructive Pelvic Surgery faculty.

Exclusion criteria

  • inability to provide consent
  • <18 years old
  • non-English speaking
  • patients using intermittent self-catheterization
  • patients sustaining bladder injury during surgery
  • prisoners
  • pregnant women

Treatment and study plan

Bladder catheter: OPTION-vf patient controlled catheter vs. indwelling transurethral catheter with leg bag

Device

OPTION-vf patient controlled catheter (transurethral catheter with external drainage valve to provide on-demand drainage of urine stored directly from the bladder), worn maximum of 30 days post-op until bladder challenge is passed. Bladder challenge is considered "passed" when a patient is able to void adequately and spontaneously (without the assistance of a catheter).

Other names: OPTION-vf™ Valved Female Urinary Catheter, Patient Controlled Catheter

Transurethral catheter with leg bag

Device

Transurethral catheter w/leg bag urine storage, worn maximum of 30 days post-up until bladder challenge is passed. Bladder challenge is considered "passed" when a patient is able to void adequately and spontaneously (without the assistance of a catheter).

Other names: Foley catheter

Primary outcomes

  1. Total Catheter Related Pain

    Time frame: 5-10 days postoperatively

    Total Catheter Related Pain Range Scale (0 = none, to 10 = worst) on the Post Operative Questionnaire All subjects were given and appointment for an outpatient voiding trial after hospital discharge. The Post Operative questionnaire was completed by the subject one time at that appointment.

Secondary outcomes

  1. Composite Satisfaction Score (CSS)

    Time frame: 5-10 days postoperatively

    The mean scores for the first 5 questions of the Post Operative Questionnaire were used to calculate a Composite Satisfaction Score.

    • Total Pain (0 none, 10 worst)
    • Total Catheter Related Pain Range Scale (0 none, 10 worst)
    • Ease of catheter use (0 easy, 10 difficult)
    • Feeling of frustration (0 none, 10 very much)
    • Limited social activities (0 none, 10 very much) All subjects were given and appointment for an outpatient voiding trial after hospital discharge. The Post Operative Questionnaire was completed by the subject one time at that appointment.

Sponsors and collaborators

Lead sponsor

University of Massachusetts, Worcester

Other

Registry information

Official study title

Clinical Trial of Patient Operated Valved Catheter Compared With Standard Indwelling Transurethral Catheter for Postoperative Bladder Management

Important dates

Study start
2011
Primary completion
2015
Study completion
2015
First posted
Oct 26, 2011
Registry last updated
May 4, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.